146 related articles for article (PubMed ID: 38710946)
1. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
Zeng F; Guo P; Xia M; He M
J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
[TBL] [Abstract][Full Text] [Related]
3. The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study.
Dong M; Gu X; Ma T; Mi Y; Shi Y; Fan R
Sci Prog; 2021; 104(2):368504211009336. PubMed ID: 33848229
[TBL] [Abstract][Full Text] [Related]
4. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
Wang R; Xiao Y; Ma L; Wu Z; Xia H
Gynecol Obstet Invest; 2022; 87(6):398-405. PubMed ID: 36273460
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
6. Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
Liu J; Lyu Y; He Y; Ge J; Zou W; Liu S; Yang H; Li J; Jiang K
J Endocrinol Invest; 2024 Jun; 47(6):1545-1557. PubMed ID: 38170396
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
Jiang AG; Cai X
BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment for neuroendocrine carcinoma of the uterine cervix.
Kasamatsu T; Sasajima Y; Onda T; Sawada M; Kato T; Tanikawa M
Int J Gynaecol Obstet; 2007 Dec; 99(3):225-8. PubMed ID: 17897648
[TBL] [Abstract][Full Text] [Related]
9. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
Melamed A; Margul DJ; Chen L; Keating NL; Del Carmen MG; Yang J; Seagle BL; Alexander A; Barber EL; Rice LW; Wright JD; Kocherginsky M; Shahabi S; Rauh-Hain JA
N Engl J Med; 2018 Nov; 379(20):1905-1914. PubMed ID: 30379613
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
Zhang X; Lv Z; Lou H
BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
12. Distant organ metastasis patterns and prognosis of neuroendocrine cervical carcinoma: a population-based retrospective study.
Li Q; Yu J; Yi H; Lan Q
Front Endocrinol (Lausanne); 2022; 13():924414. PubMed ID: 36051393
[TBL] [Abstract][Full Text] [Related]
13. Patterns of recurrence and survival in neuroendocrine cervical cancer.
Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
[TBL] [Abstract][Full Text] [Related]
14. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
[TBL] [Abstract][Full Text] [Related]
15. Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
Yu C; Wu X; Zhang S; Zhang L; Zhang H; Yang H; Zhao M; Li Z
PLoS One; 2024; 19(1):e0296446. PubMed ID: 38181016
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
Kim JH; Shim SH; Nam SH; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
J Minim Invasive Gynecol; 2020; 27(7):1558-1565. PubMed ID: 32084588
[TBL] [Abstract][Full Text] [Related]
17. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
Nasioudis D; Latif NA; Giuntoli Ii RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Ko EM
Int J Gynecol Cancer; 2021 Jun; 31(6):829-834. PubMed ID: 33962994
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
